Cerebras Systems raised the price range for its initial public offering to $150–$160 per share, marking a 13% increase from the midpoint of its original filing. The AI chipmaker is also enlarging the deal size, according to two people familiar with the terms. The move, expected to be formalized as early as Monday, reflects institutional demand that exceeded the company's original allocation by a multiple the sources declined to specify.

The revision puts Cerebras on track to raise north of $800 million in gross proceeds, assuming the offering prices at the top of the new range and includes the standard greenshoe. That figure excludes any concurrent private placement or strategic anchor allocation, which Cerebras has not yet disclosed. The company originally targeted a $133–$143 range when it filed its S-1 in late March, valuing the business at roughly $7.2 billion pre-money at the midpoint. The new range implies a post-money valuation approaching $9 billion, depending on final share count and over-allotment mechanics.

Cerebras designs wafer-scale AI accelerators—single chips spanning an entire 300mm silicon wafer—that compete directly with NVIDIA's H100 and H200 GPUs for large-language-model training workloads. The company's CS-3 system integrates 900,000 cores on a single die, eliminating the latency and memory-bandwidth bottlenecks that plague multi-GPU clusters. Revenue grew 67% year-over-year in 2023, though the company remains unprofitable as it scales manufacturing capacity with TSMC and builds out its Condor Galaxy supercomputer installations for Abu Dhabi's G42 and other sovereign AI customers.

The pricing adjustment is rare outside of enterprise SaaS or consumer-facing offerings with transparent unit economics. Hardware IPOs typically hold their initial range to avoid signaling production risk or supply-chain fragility. That Cerebras felt confident enough to reprice upward suggests its order book is binding and backed by credible purchase commitments, not speculative demand. The two-to-three-year lock-in contracts the company uses for its cloud inference customers provide revenue visibility that public equity buyers are willing to pay for in a market otherwise skeptical of capital-intensive hardware bets.

Allocators should track the final pricing decision and the composition of the investor base when the deal prices, likely within five trading days. If sovereign wealth funds or strategic corporates take anchor stakes, it signals that Cerebras is being positioned as critical infrastructure rather than a speculative growth story. The greenshoe exercise within 30 days will reveal whether underwriters need to stabilize the stock or if secondary demand holds. Any partnership announcements with hyperscalers—AWS, Azure, or Google Cloud—in the 90-day quiet period following the IPO would validate the thesis that wafer-scale architecture is gaining traction outside of niche research labs.

The offering is led by Citigroup, Barclays, and HSBC. Trading is expected to begin on the Nasdaq under the ticker CBRS within the week.